Sex-Specific Changes and Correlates of Intimate Partner Violence in Kenya: Analyses of Nationally Representative Surveys From 2014 and 2022
Journal of Interpersonal Violence · 2026
DOI: 10.1177/08862605261444013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interpersonal Violence, 2026. Verfasst von Anne Abio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Child Psychiatry, University of Turku, Finland. Hauptthemen laut MEDLINE: Intimate Partner Violence. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intimate partner violence (IPV) impacts both females and males with long-lasting consequences. The study investigated changes in IPV, co-occurrence of multiple forms of violence, and factors associated with IPV among females and males in Kenya. We used secondary data from the 2014 and 2022 Kenyan Demographic Health Surveys. Logistic regression analysis was used to estimate changes in IPV and the association with explanatory factors stratified by sex. Among females, lifetime prevalence of any IPV was stable in 2014 versus 2022 (47.1% vs. 46.3%; OR = 1.09, 95% CI [0.98, 1.22]), and in the past year (32.6% vs. 31.1%; OR = 1.05, 95% CI [0.94, 1.18]). Psychological IPV among women increased modestly (lifetime OR = 1.31, 95% CI [1.17, 1.47]; 12-month OR = 1.18, 95% CI [1.04, 1.34]). Among males, lifetime prevalence of any IPV rose from 23.4% to 29.7% ( OR = 1.78, 95% CI [1.50, 2.12]), psychological IPV from 20.4% to 26.5% ( OR = 1.77, 95% CI [1.48, 2.12]), and sexual IPV from 3.8% to 4.9% ( OR = 1.68, 95% CI [1.16, 2.45]). Past‑12‑month any IPV ( OR = 1.38, 95% CI [1.14, 1.66]) and psychological IPV ( OR = 1.43, 95% CI [1.18, 1.73]) also increased. Across both sexes, older age, father beat mother, and perpetration of physical violence were associated with higher odds of IPV, while higher education was associated with lower odds of IPV among women but higher odds among men. Lifetime co-occurrence of three forms of IPV were reported at 8.5% versus 7.9% in women, and 1.4 versus 1.1% in men (2014 vs. 2022). While overall IPV among women remained unchanged in 2014 and 2022, psychological violence rose, and men reported significant increases in both lifetime and recent IPV. Distinct sex-specific patterns in associated factors underscore the need for sex-responsive and inclusive IPV prevention strategies, particularly interventions addressing psychological abuse and intergenerational violence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Centre for Child Psychiatry, University of Turku, Finland.
- INVEST Research Flagship Center, University of Turku, Finland.
- Injury Epidemiology and Prevention (IEP) Research Group, Turku Brain Injury Centre, Department of Clinical Neurosciences, Turku University Hospital and University of Turku, Finland.
- Heidelberg Institute of Global Health (HIGH), University Hospital and University of Heidelberg, Germany.
ORCID-Profile: Anne Abio, Jacinta Mukulu Waila
Zitieren
APA
Abio, A., MohammadNamdar, M., Dadras, O., Lowery Wilson, M., & Waila, J. M. (2026). Sex-Specific Changes and Correlates of Intimate Partner Violence in Kenya: Analyses of Nationally Representative Surveys From 2014 and 2022. Journal of Interpersonal Violence. https://doi.org/10.1177/08862605261444013
Vancouver
Abio A, MohammadNamdar M, Dadras O, Lowery Wilson M, Waila JM. Sex-Specific Changes and Correlates of Intimate Partner Violence in Kenya: Analyses of Nationally Representative Surveys From 2014 and 2022. Journal of Interpersonal Violence. 2026. doi:10.1177/08862605261444013
BibTeX
@article{Abio2026,
author = {Abio, Anne and MohammadNamdar, Mahsa and Dadras, Omid and Lowery Wilson, Michael and Waila, Jacinta Mukulu},
title = {Sex-Specific Changes and Correlates of Intimate Partner Violence in Kenya: Analyses of Nationally Representative Surveys From 2014 and 2022},
journal = {Journal of Interpersonal Violence},
year = {2026},
doi = {10.1177/08862605261444013}
}
EUVIMED